BAILARD, INC. Q1 2022 Filing

Filed April 25, 2022

Portfolio Value

$3.0T

Holdings

715

Report Date

Q1 2022

Filing Type

13F-HR

All Holdings (715 positions)

#StockSharesValue% PortfolioType
701
OSSONE STOP SYS INC
17,774$68.0M0.00%
702
SANBANCO SANTANDER S.A.
19,396$66.0M0.00%
703
AILERON THERAPEUTICS INC
128,010$66.0M0.00%
704
FSIFLEXIBLE SOLUTIONS INTL INC
15,124$62.0M0.00%
705
LPTXEURLEAP THERAPEUTICS INC
34,700$61.0M0.00%
706
DECIBEL THERAPEUTICS INC
19,700$60.0M0.00%
707
PIRSPIERIS PHARMACEUTICALS INC
19,600$59.0M0.00%
708
CLSDUSDCLEARSIDE BIOMEDICAL INC
25,600$59.0M0.00%
709
ELEVATION ONCOLOGY INC
23,500$59.0M0.00%
710
SGRPSPAR GROUP INC
44,300$58.0M0.00%
711
UREUR-ENERGY INC
36,200$58.0M0.00%
712
CALITHERA BIOSCIENCES INC
122,285$49.0M0.00%
713
BWENBROADWIND INC
18,000$39.0M0.00%
714
NERVGBPMINERVA NEUROSCIENCES INC
24,400$20.0M0.00%
715
CASI PHARMACEUTICALS INC
25,100$20.0M0.00%
PreviousPage 8 of 8